Article
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020.
Molecular diagnosis & therapy - 1 Jun 2020
Has Cristina, South Andrew, Uitto Jouni
Abstract excerpt
Epidermolysis bullosa (EB) is a group of rare genetic disorders for which significant progress has been achieved in the development of molecular therapies in the last few decades. Such therapies require knowledge of mutant genes and specific mutations, some of them being allele specific. A relatively large number of clinical trials are ongoing and ascertaining the clinical efficacy of gene, protein or cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.